Christer Ahlberg discusses HEEALING1 ahead of topline results
At Swiss Nordic Bio 2026, Cinclus Pharma CEO Christer Ahlberg joined BiotechTV to discuss the company’s ongoing Phase III HEEALING1 trial.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Christer Ahlberg presents at Biostock Investing in Life Science in Stockholm
Watch the presentation by Cinclus Pharma's CEO Christer Ahlberg at Biostock Investing in Life Science 2026 in Stockholm from September 22.
Read more
Christer Ahlberg interviewed by Redeye about the Q2 report and HEEALING1
Cinclus Pharma CEO Christer Ahlberg discusses the Q2 2026 Interim Report and provides an update on the Phase III HEEALING1 trial in an interview with Redeye.
Read more